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Vascular endothelial growth factor-A (VEGF-A) signaling directs both vasculogenesis and angiogenesis. However, the role of VEGF-A ligand
signaling in the regulation of epithelial–mesenchymal interactions during early mouse lung morphogenesis remains incompletely characterized.
Fetal liver kinase-1 (Flk-1) is a VEGF cognate receptor (VEGF-R2) expressed in the embryonic lung mesenchyme. VEGF-A, expressed in the
epithelium, is a high affinity ligand for Flk-1. We have used both gain and loss of function approaches to investigate the role of this VEGF-A
signaling pathway during lung morphogenesis. Herein, we demonstrate that exogenous VEGF 164, one of the 3 isoforms generated by alternative
splicing of the Vegf-A gene, stimulates mouse embryonic lung branching morphogenesis in culture and increases the index of proliferation in both
epithelium and mesenchyme. In addition, it induces differential gene and protein expression among several key lung morphogenetic genes,
including up-regulation of BMP-4 and Sp-c expression as well as an increase in Flk-1-positive mesenchymal cells. Conversely, embryonic lung
culture with an antisense oligodeoxynucleotide (ODN) to the Flk-1 receptor led to reduced epithelial branching, decreased epithelial and
mesenchymal proliferation index as well as downregulating BMP-4 expression. These results demonstrate that the VEGF pathway is involved in
driving epithelial to endothelial crosstalk in embryonic mouse lung morphogenesis.
D 2005 Elsevier Inc. All rights reserved.Keywords: Vascular endothelial growth factor-A (VEGF-A); Fetal liver kinase-1 (Flk-1); Bone morphogenetic protein-4 (BMP-4); murine Sprouty-2 (mSpry-2);
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Embryonic lung development begins by evagination of the
laryngo-tracheal groove from the foregut endoderm. Two distal
buds subsequently branch laterally into the surrounding
mesodermal mesenchyme. While extensive analysis of endo-
dermal branching morphogenesis to form the lungs has been
done (Chuang and McMahon, 2003; Hogan and Yingling,
1998; Warburton et al., 2000), relatively little is known about
growth and differentiation of the lung mesenchyme. However,
it is known that vasculogenesis, or in situ differentiation of0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: dwarburton@chla.usc.edu (D. Warburton).endothelial precursors and assembly into a network, is already
initiated within the mesenchyme as the lung evaginates from
the foregut (Gebb and Shannon, 2000). Moreover, the Vascular
Endothelial Growth factor (VEGF) family of ligands and their
cognate receptors FMS-like tyrosine kinase 1 (Flt-1) or VEGF-
R1, and Fetal Liver Kinase-1 (Flk-1) or VEGF-R2, affect a
wide variety of physiological and pathological events (Ferrara
et al., 2003).
VEGF-A is a specific endothelial cell mitogen (Leung et al.,
1989), as well as playing a chemoattractant role for endothelial
cells, osteoclasts and monocytes (Yoshida et al., 1996). In the
mouse, alternative splicing of a single Vegf-A gene generates 3
isoforms: Vegf 120, 164, and 188, corresponding to the number
of amino acids in each isoform (Shima et al., 1996). VEGF 164
is the major endothelial mitogenic factor among the 3 different
VEGF isoforms (Keyt et al., 1996). While Vegf-A is restricted90 (2006) 177 – 188
www.e
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(Vegf-r1) and Flk-1 (Vegf-r2) are expressed by endothelial
cells, Flk-1 appears to be the main receptor mediating the
mitogenic and chemotactic effect of VEGF-A on the endothe-
lium (Clauss et al., 1996). Flt-1, on the other hand appears to
have a role in cell migration rather than cell proliferation
(Barleon et al., 1996).
The essential role of the VEGF pathway during develop-
ment has been demonstrated by gene targeting analysis. The
loss of a single Vegf-A allele (Vegf-A+/) resulted in a lethal
phenotype around mouse embryonic day 11.5 (E 11.5),
associated with defects in the formation of the yolk sac
vessels and of the dorsal aorta (Ferrara et al., 1996). A similar
defect in embryonic blood vessel development was observed
in heterozygous Vegf-A null embryos, and an even more
severe defect has been observed in homozygous Vegf-A null
embryos resulting in a lethal phenotype around mid-gestation
(Carmeliet et al., 1996). Thus, the observed phenotypes
suggest a dose-dependent effect of VEGF-A on embryonic
vasculogenesis. Additionally, increased expression of VEGF-
A has been shown to disrupt embryonic development,
resulting in lethal heart defects around E14 (Miquerol et al.,
2000).
Moreover, homozygous null Flk-1 mutants die in utero at
E8.5, lacking mature endothelial and haematopoietic cells,
but also exhibiting an absence of blood island formation
(Shalaby et al., 1995). Inactivation of the other VEGF
receptor, Flt-1, also leads to a lethal phenotype around E 9.5.
These embryos exhibit an excess of endothelial cells
associated with a disorganized vascular network (Fong et
al., 1995). However, the tyrosine kinase domain of Flt-1 per
se does not seem to participate in embryonic development,
since no developmental abnormalities have been observed in
embryos expressing a mutated Flt-1 tyrosine kinase domain
(Hiratsuka et al., 1998).
Taken together, the above data indicate a major role for
VEGF-A and its cognate receptor Flk-1 during embryogenesis.
During lung organogenesis, VEGF 120 and 164 isoforms are
diffusely expressed in pulmonary epithelial and mesenchymal
cells around E12.5, and are involved in controlling endothelial
proliferation and the maintenance of vascular structure (Green-
berg et al., 2002). Also, as epithelial morphogenesis progresses
Vegf-A expression becomes restricted to the distal lung (Healy
et al., 2000). This observation is postulated to be due in part to
the relatively high affinity of VEGF-A for matrix components,
that concentrates VEGF-A around the branching lung tips
(Acosta et al., 2001; Ng et al., 2001).
To test the functional role of VEGF-A during early
embryonic lung epithelial and vascular morphogenesis, we
compared the effects of exogenous VEGF 164 with those of
antisense ODN to Flk-1 receptor on early embryonic lung
morphogenesis in serumless chemically defined organ culture.
Herein, we show that exogenous VEGF 164 increases
embryonic lung epithelial as well as endothelial branching
morphogenesis, whereas Flk-1 antisense ODN decreases
epithelial as well as endothelial lung branching in culture.
VEGF-A signaling also differentially regulates the expressionof BMP-4, mSpry-2, mSpry-4 and Sp-c as well as the
proliferation of both the epithelial and mesenchymal compart-
ments. Therefore, we conclude that VEGF-A signaling plays a
key functional role in mediating crosstalk between the
epithelial, mesenchymal and endothelial compartments during




Timed-pregnant Swiss webster mice were sacrificed on postcoitum day 11
(E11) or 12 (E12) and the embryos were removed. Lung primordia were
isolated from embryos (E11 and E12) by microdissection. Dissection was
carried out under sterile conditions using microophthalmic surgical instruments
and a dissecting microscope. Early mouse embryonic lung lungs were cultures
under serum-free, chemically defined conditions as reported previously (Jaskoll
et al., 1988; Warburton et al., 1992). Embryonic lung explants were placed on
0.80-Am MF-Millipores filters (Millipore, Bedford, MA), supported by
stainless-steel grids in Grobstein culture dishes (Flacon, Lincoln Park, NJ)
and cultured in BGJb medium (Gibco, Grand Island, NY) supplemented with
0.1 mg/ml ascorbic acid and 50 units/ml penicillin/streptomycin. About 1 ml
medium was added to each dish to establish an air fluid interface at the level of
the explants. The cultures were maintained in 100% humidity with an
atmosphere of 95% air and 5% CO2 for 2 or 3 days. The medium was
changed every day.
Exogenous VEGF and Flk-1 antisense ODN treatment
Exogenous recombinant murine VEGF 164 (R&D, Minneapolis, MN) was
added to cultured E11 lung explants. A dose– response analysis was done using
different VEGF 164 concentrations in the culture media (80 ng/ml, 100 ng/ml,
and 150 ng/ml). There was an increased morphogenetic effect using 80 ng/ml
and 100 ng/ml versus, but no additional differences were observed between 100
ng/ml and 150 mg/ml of VEGF 164. Therefore, a VEGF 164 concentration of
100 ng/ml was maintained during culture by replacing the media every 24 h.
Phosphorothioate ODNs were purified by HPLC at the USC Comprehensive
Cancer Center (Los Angeles, CA). The antisense oligomer sequence was
selected following (Marchand et al., 2002) and had specific characteristics (no
more than three consecutive guanosines, the incapacity to form hairpins without
or minimal capacity to dimerize together, and was 18 bases in length). The
murine Flk-1 cDNA was obtained from GenBank (Accession Numbers
X70842). Antisense or scrambled ODNs were added separately to the culture
medium at a final concentration of 40 AM. The oligonucleotides used were
separately: Flk-1 antisense ODN 5V-AgT ATg TCT TTC TgT gTg-3V, versus
scrambled ODN 5V-TTT CTg gTA TgC ATT gTg-3V as negative control. The
oligomers were used under sterile conditions.
Quantification of branching morphogenesis
We quantified branching on whole-mount lung explants by counting the
number of epithelial sacs around the periphery of the lung explants.
Transillumination was used to detect structures and photomicrography was
used to record permanent images. Branching was counted for four to six lungs
per data point and statistical significance was determined by ANOVA and t test
(values were considered significant if P < 0.05).
Flk-1nLac-Z/+ and Bmp-4LacZ/+ staining
Heterozygous Flk-1nLac-Z/+ and Bmp-4LacZ/+ mice (Lawson et al., 1999;
Shalaby et al., 1995) were, respectively, obtained from Jackson Laboratories
and as a gift from Dr. Hogan. Dissected heterozygous lungs were fixed in 4%
paraformaldehyde and reacted with X-gal as described by (Lawson et al.,
1999). Vibratome sections (20 Am) of the caudal lobe were then made.
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E12.5 mouse lung were isolated and treated with undiluted dispase (BD
Biosciences, San Jose, CA) for 30 min at 4-C. The lung mesenchyme was
separated from the epithelium using fine tungsten needles and transferred into
Matrigeli, diluted 1:1 with culture medium (5% FCS (DMEM: F12)
penicillin/streptomycin + glutamine) in a four well dish (Nalgene Nunc,
Rochester, NY). Polymerization of the Matrigeli was triggered at 37-C for 30
min. After polymerization, 500 Al of culture medium containing the growth
factor VEGF (150 ng/ml) was gently added to the Matrigeli layer. The
respective epithelial versus mesenchymal explants were grown for 48 h at 37-C
in a 5% CO2 incubator. Explants were fixed in 4% paraformaldehyde and
reacted with X-gal as described by (Lawson et al., 1999).
RNA extraction and reverse transcription
Lungs were harvested and total RNA was extracted using Total RNA
Isolation kit (5VPrime–3VPrime, West Chester, PA). The RNA was reverse-
transcribed by incubating the samples at 37-C for 1 h in 20 Al of 10 mMTris (pH
8.4), 2 mM MgCl2, 50 mM KCl, 1 mM dithiothreitol, 0.5 mM dNTP, 5 units
ribonuclease inhibitor, 100 pmol oligo (dT)12–18 and 200 units MMLV reverse
transcriptase (USB, Cleveland, OH). The reaction was terminated by incubation
for 5 min at 95-C. Spectrophotometry was used to determine cDNA
concentration (A260, 50 Ag/ml). The reverse-transcribed samples were then used
for competitive PCR.
Competitive RT-PCR
Competitive RT-PCR was performed as previously described (Zhao et al.,
1998) to determine the effects of treatment on mRNA levels in the lungs.
The same primers were used to amplify both cDNA and competitor for each
gene of interest. A cDNA/competitor scale was designed using a fixed
concentration of competitor with scaled concentrations of cDNA. The log of
cDNA/competitor was plotted against the target concentration, resulting in a
coefficient r2 > 0.98. Competitive PCR quantification provides an accurate
assessment of mRNA levels and is reliable in the absence of contaminating
DNA species. PCR was performed in a Robocyler (Stratagene, La Jolla,
CA). The first cycle consisted of an initial 3 min denaturation at 94-C,
annealing at 62-C for 1 min, and extension at 72-C for 2 min. The next 30
cycles were similar except for a 1-min denaturation period and in the last
cycle the extension period lasted 5 min. The reaction mixture contained 20
pmol primers, 10 mM Tris (pH 9.4), 50 mM KCl, 2 mM MgCl2, 0.01%
gelatin, 0.1% Triton X-100, 100 AM dNTP and 0.5 units of Advantage
Clontech DNA polymerase (Clontech, Palo Alto, CA). A known amount of
competitor was added to products of reverse transcription. Competitive PCR,
using b-actin, was also performed with all samples as a positive control. The
primers used for amplification were as follows: Fgf10 forward primer, 5V-
CACATTGTGCCTCAGCCTTTCC-3V; Fgf10 reverse primer, 5V-CC
TGCCATTGTGCTGCCAGTTAA-3V (predicted size 505 bp); mSpry2 for-
ward primer, 5V-TGTGAGGACTGTGGCAAGTGC-3V; mSpry2 reverse prim-
er, 5V-TTTAAGGCAACCCTTGCTGG-3V (predicted size 300 bp); Bmp4
forward primer, 5V-TCCATCACGAAGAACATC-3V; Bmp4 reverse primer, 5V-
TAGTCGTGTGATGAGGTG-3V (predicted size 238 bp); Shh forward
primer, 5V-GCTGCTGGCCAGATGTTTTCTG-3V; Shh reverse primer, 5V-
TCCAGGCCACTGGTTCATCACA-3V (predicted size 351 bp); Flk-1 for-
ward primer, 5V-ACTGGAGCCTACAAGTGCTCGT-3V; Flk-1 reverse primer,
5V-TGAGGTTTGAAATCGACCCTCG (predicted size 181 bp); Sp-c forward
primer, 5V-TGGTCCTTGAGATGAGCATCGG; Sp-c reverse primer, 5V-
GTAGAGTGGTAGCTCTCCACAC (predicted size 360 bp); mSpry4 for-
ward primer, 5V-GTGTCTGGTGCAAGGTATCTTC; mSpry4 reverse primer,
5V-TCAGAAAGGCTTGTCAGACCTG (predicted size 300 bp).
Quantification of cDNA and statistical analysis
Target cDNA and competitor PCR products were separated by electropho-
resis in a 3% agarose gel (3:1 mixture of Nusieve and Seakem; FMC,
Rockland, ME). The gel was run on a submarine gel apparatus (C.B.S.Scientific Co., Del Mar, CA) and stained with 5 Ag/ml ethidium bromide.
Photographs were taken with Polaroid 667 film and the intensity of the bands
was determined by densitometry.
Western blot analysis
Cultured embryonic lungs were disrupted immediately in SDS buffer
containing protease inhibitors and sodium fluoride. Equal amounts of total
lung protein (50 Ag) from each assayed sample were used for chemilumi-
nescent Western analysis (Roche Molecular Biochemicals) on Immuno-Blot
PVDF membrane (Bio Rad, Hercules, CA). Immunoblotting was performed
using antibodies against human BMP-4 (R&D systems, Minneapolis, MN),
and Mouse anti-actin (ICN Biomedicals, Aurora, OH) at recommended
dilutions (1:1000 for the BMP-4 antibody, and 1:10,000 for the actin
antibody).
Analysis of lung proliferation ex vivo
Dehydrated lungs were embedded in paraffin and sections (6 Am) were cut.
Proliferation was measured using the PCNA kit (Zymed) following the
manufacturer’s instructions. All cells were counted and scored in five
photomicrographs, at 50 magnification, of random portions of a section of
treated versus control lungs. At that stage, it was possible to distinguish clearly
between epithelial and mesenchymal cells and the PCNA index was calculated
for the epithelial and mesenchymal compartments.
Data analysis
The data in the present study were expressed as mean T SD, and the
significance of variances between means was evaluated by ANOVA followed by
Student’s t test. P values less than 0.05 were considered to be statistically
significant.
Results
VEGF does not induce branching of isolated lung endoderm
but does induce amplification of Flk-1-positive cells in the
mesenchyme
We initially analyzed the expression pattern of Flk-1 receptor
in E14.5 Flk-1nLacZ/+ lungs. The beta-galactosidase staining
corresponding to Flk-1 expression in this tissue revealed
exclusive expression of the receptor in the mesenchyme (Figs.
1A, B). We then isolated E12.5 embryonic lung endoderm from
mesenchyme and cultured it in matrigel for 48 h in the presence
of VEGF 164. We observed that VEGF 164 did not induce
epithelial branching in isolated lung endoderm (Figs. 1C, D).
FGF10, used as a positive control in our experiments, induced
growth and budding as already described (Bellusci et al., 1997),
therefore attesting to the viability and responsiveness of the
isolated endoderm (data not shown). In contrast, mesenchymal
explants cultured with VEGF 164 exhibited striking increases in
h-galactosidase staining representing Flk-1-positive cells (Fig.
1F). Control mesenchyme did not contain any Flk-1-positive
cells (Fig. 1E).
VEGF 164 stimulates epithelial branching morphogenesis on
the whole lung in culture
We initially observed that lung buds from 11-day mouse
embryos cultured in vitro for 24 h, 48 h, and 72 h in a
Fig. 1. VEGF 164 does not induce branching of isolated lung endoderm but does
induce differentiation of Flk-1-positive cells in isolated mesenchyme. Analysis
of the expression pattern of Flk-1 on E14.5 Flk-1n LacZ/+ lungs on whole lung
(A) and 30 Am vibratome section of the caudal lobe (B) show the staining
corresponding to Flk-1 expression only in the mesenchyme (arrowhead M) and
not in the bronchial and distal endoderm (arrowhead B and E, respectively) at
that stage of development. Culture of isolated embryonic lung endoderm (C, D)
versus mesenchyme (E, F) in matrigel from 0 h (insets in C–F) to 48 h (C–F) in
presence or absence of VEGF 164 revealed an exclusive morphogenic effect on
the mesenchyme (F). h-galactosidase staining representing Flk-1-positive cells
is detected only in VEGF 164-treated mesenchyme, whereas Flk-1 staining was
absent in the control mesenchyme after 48 h (E, F). Scale bar represents 80 mm
in main panels C–F, and 200 mm in insets within C–F.
Fig. 2. VEGF 164 stimulates epithelial branching morphogenesis. E11 lungs
treated with VEGF 164 (150 ng/ml) for 48 h (B) or 72 h (F) showed
significantly increased epithelial branching morphogenesis compared with
untreated lungs (A, E). Higher magnification of respective lungs with epithelia
boundaries outlined for the purpose of illustration also showed increased
branching of the endoderm in the VEGF 164-treated explants (C, D, G, H)
Terminal branches were counted and VEGF 164 was found to significantly
increase lung branching (*P < 0.05) by 60% T 3% after 48 h (not shown) and
80% T 5% after 72 h (I). Results are presented as means T SD, n = 15, of a
least 3 independent experiments.
P.-M. Del Moral et al. / Developmental Biology 290 (2006) 177–188180chemically defined media containing recombinant mouse
VEGF 164 (100 ng/ml) appeared to be much more highly
branched than the lung buds grown in control medium (Fig. 2).
The stimulation of branching by VEGF was quantified by
counting terminal branches (compare Figs. 2G to H). VEGF
164 increased the number of terminal branches by 60% T 3%
after 48 h (data not shown) and by 80% T 5% after 72 h of
culture (P < 0.05) (Fig. 2I).
Effect of VEGF 164 on Flk-1nLac-Z/+ expression and specific
gene expression
In order to confirm the biological activity of recombinant
VEGF 164 on endothelial cells, we cultured embryonic
heterozygous Flk-1nLac-Z/+ lungs in the same conditions asl
.
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pattern of h-galactosidase staining and therefore in Flk-1
expression is seen in the VEGF-treated lungs compared to the
control lungs (Figs. 3A–D). Given the significant increase in
branching morphogenesis, we investigated the expression of
specific genes that are characteristic of FGF10 signaling
pathway (murine Sprouty2, murine Sprouty4), bone morpho-
genetic protein (Bmp-4), as well as the specific peripheral
epithelial cell marker (Sp-c). Increased expression of the Sp-c
gene correlates with increasing functional maturity of the lung
(Weaver, 1991). Sp-c is also a specific marker for the alveolar
type II cell lineage. We used a sensitive competitive RT-PCR
assay to measure the relative expression levels of these specific
mRNAs in control versus VEGF 164-treated lungs. As
expected from our previous experiments (Figs. 3A–D), we
found that, compared to control lungs, exposure to exogenous
VEGF 164 significantly (P < 0.05) increased the levels of
mRNA encoding Flk-1 receptor (142%) (Fig. 3F and Table 1).
Sp-c expression was also increased (141%) as well as Bmp-4
mRNA levels (139%) (Figs. 3H, J), whereas Shh and Fgf10
expression remained unchanged (data not shown). In contrast,
VEGF treatment decreased both mSpry-2 and mSpry-4 gene
expression to 41% and 43% of the level of expression observed
in control lungs (Figs. 3G, I).
Flk-1 antisense ODN decreases Flk-1nLac-Z/+ expression and
inhibits epithelial branching morphogenesis
Flk-1 was tested for its functional role during embryonic
lung organogenesis using an antisense oligodeoxynucleotide
approach. This approach also allowed us to test the
functionality of Flk-1 antisense ODN by culturing embryonic
Flk-1nLac-Z/+ lungs in absence or presence of this oligodeox-
ynucleotide. As negative control and to test whether exogenous
DNA sequence would be toxic to the lung explants, we also
cultured Flk-1nLac-Z/+ lungs in a media containing a scrambled
sequence comprising the same nucleotides as in the Flk-1
antisense ODN, but in a nonsensical order termed scrambled
ODN. A readily apparent decrease in h-galactosidase staining
and therefore in Flk-1 expression is seen in the Flk-1 antisense
ODN-treated lungs compared to the control versus scrambled
treated lungs (Figs. 4A, C, E). The efficacy of Flk-1 antisense
ODN was confirmed by competitive PCR quantification ofFig. 3. VEGF 164 stimulates Flk-1 n Lac-Z/+ expression. h-galactosidase staining
on untreated Flk-1n Lac-Z/+ lungs (A) clearly was much less intense than in
VEGF 164-treated lungs (150 ng/ml) (B). Higher magnification shows also the
pattern of endothelial branching in the VEGF 164-treated lungs compared to
the untreated lungs (arrows in C, D). Effect of VEGF 164 on specific gene
expression (E–K). Quantification of competitive RT-PCR data by densitomet-
ric analysis with normalization to h-actin (K). VEGF 164 treatment (150 ng/ml)
significantly decreased endogenous mSpry-2 (G), mSpry-4 (I) mRNA levels to
41% and 43% (P < 0.05), respectively of their level of expression observed in
control lungs. While, Flk-1 (O), Sp-c (Q), and Bmp-4 (S) mRNA levels
increased by 142%, 141% and 139%, respectively, in the VEGF-treated lungs
compared to control lungs (*P < 0.05). No change in Shh or Fgf10 expression
was observed (not shown). Values are expressed as the mean T SD with the
medium control set at 100%. Results are presented as means T SD, n = 15,
combining at least 3 independent experiments.Flk-1 mRNA level in cultured embryonic lungs. As shown in
Fig. 5B, 40 AM Flk-1 antisense ODN efficiently (P < 0.05)
attenuated Flk-1 mRNA expression by over 90% in comparison
to both media control and scrambled ODN. The scrambled ODN
had no inhibitory effect on Flk-1 mRNA expression. Therefore,
the observed effect upon lung branching morphogenesis with
Flk-1 antisense ODN treatment resulted from abrogation of
Flk-1 gene expression. While both control and scrambled ODN
did not change lung branching (Figs. 4G, K), Flk-1 antisense
ODN caused a significant decrease of embryonic lung epithelial
Table 1













b-actin Control Competitor 2278 T 158 1.50 1.06 +6
Gene 3410 T 182
VEGF Competitor 2516 T 101 1.58
Gene 3976 T 226
Flk-1 Control Competitor 1466 T 120 1.39 2.42 +142
Gene 2034 T 192
VEGF Competitor 1885 T 139 3.36
Gene 6334 T 471
Sp-c Control Competitor 3245 T 324 0.63 2.41 +141
Gene 2054 T 251
VEGF Competitor 3402 T 274 1.53
Gene 5197 T 526
mSpy2 Control Competitor 2857 T 178 1.17 0.41 59
Gene 3334 T 301
VEGF Competitor 3039 T 292 0.48
Gene 1467 T 175
mSpry4 Control Competitor 4365 T 470 0.75 0.43 57
Gene 3291 T 269
VEGF Competitor 4123 T 371 0.32
Gene 1328 T 184
Bmp-4 Control Competitor 5678 T 283 0.57 2.39 +139
Gene 3239 T 196
VEGF Competitor 4181 T 125 1.37
Gene 5709 T 348
Quantification of competitive RT-PCR data by densitometric analysis. For each gene, the density of the band corresponding to the gene or the competitor was
measured as Intensity/mm2 T SD. A ratio of gene/competitor was then determined for the control or the VEGF-treated explants. The VEGF ratio was then compared
to the control ratio to determine the difference in mRNA expression in VEGF-treated versus control lung.
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number of terminal branches, Flk-1 antisense ODN decreased
epithelial branching by 38% T 4% at 40 AM (P < 0.05), while
cultured explants branched normally in the presence of control
media as well as in the presence of scrambled ODN (Fig. 4M).
Effect of the abrogation of Flk-1 receptor mRNA expression on
specific gene expression
We evaluated specific changes in gene expression induced by
the Flk-1 antisense ODN on the cultured embryonic lungs by
competitive RT-PCR (Fig. 5 and Table 2). Respectively,mSpry2
and mSpry4 mRNA levels increased by 162% and 142% (P <
0.05) in the Flk-1 antisense ODN cultured lungs (Figs. 5C, E). In
contrast, the Sp-c mRNA level was decreased by 59% of its
expression in the control and scrambled ODN-treated lungs.
Likewise, Bmp-4 mRNA levels were also reduced by 34% in the
embryonic lungs cultured with the Flk-1 antisense ODN.
Bmp-4LacZ/+ cultured lungs and Western analysis confirmed the
respective up-regulation and downregulation of BMP-4 with
VEGF 164 versus Flk-1 antisense ODN
As shown in Fig. 6, Bmp-4LacZ/+ cultured lungs treated with
VEGF 164 clearly showed increased levels of h-galactosidase
staining compared to lung cultured in control media (Figs. 6A,
B). However, in presence of Flk-1 antisense ODN, there was a
significant decrease in h-galactosidase staining compared to
control media and scrambled ODN-treated lungs (Figs. 6C–E).These changes in h-galactosidase staining only occurred within
the distal tips of the epithelium. No changes in spatial
distribution, and therefore in mesenchymal staining was
observed.
The BMP-4 antibody that we used to perform Western
analysis detects not only two distinct BMP-4 bands with
different sizes (25 kDa, 18 kDa) corresponding to different
glycosylation states of activated BMP-4, but also pro-BMP-4
(50 kDa). Flk-1 antisense ODN reduced both pro-BMP-4
protein amount as well as the level of both glycosylated forms
of activated BMP-4 (Fig. 6F). Densitometric analysis con-
firmed that exogenous VEGF 164 increased BMP-4 protein
levels by 72% T 6% (P < 0.05) compared to the lungs cultured
with control media. Conversely, BMP-4 protein amount was
decreased by 63% T 7% (P < 0.05) in the lungs cultured with
Flk-1 antisense ODN, while the scrambled ODN at the same
concentration did not have any inhibitory effect on BMP-4
proteins level. Therefore, only the Flk-1 antisense ODN, not
the scrambled ODN, resulted in a significant reduction (63%)
in the BMP-4 protein level. This result was observed
consistently over 3 different sets of experiments.
Effect of exogenous VEGF 164 versus Flk-1 antisense ODN on
epithelial and mesenchymal cell proliferation
The respective increase or decrease in branching mor-
phogenesis observed in lungs cultured with exogenous
VEGF 164 versus Flk-1 antisense ODN suggested that
these conditions may have differentially affected the rate of
Fig. 4. Flk-1 antisense ODN decreases Flk-1n Lac-Z/+ expression. h-galactosidase staining in 40 AM Flk-1 antisense ODN-treated Flk-1n Lac-Z/+ lungs (C) was clearly
decreased compared to 40 AM scrambled ODN and media control lungs (A, E). At higher magnification, endothelial branching was also clearly decreased (arrows) in
the Flk-1 antisense ODN-treated lungs (D) compared to the control and scrambled ODN-treated lungs (B, F). Abrogation of Flk-1 (VEGF-R2) receptor gene
expression by antisense ODN inhibits epithelial-branching morphogenesis. Lungs cultured in 40 AM Flk-1 antisense ODN exhibit a significantly lower epithelial
branching morphogenesis (I) compared with 40 AM scrambled ODN- and control-treated lungs (G, K). Higher magnification of respective lungs with outlined
epithelial boundaries (H, J, L) also showed a decreased branching of the endoderm in the Flk-1 antisense ODN-treated explants (J). After 72 h, Flk-1 antisense ODN
treatment decreased the number of terminal branches by 38% T 4% (*P < 0.05) (M). Results are presented as means T SD, n = 15, of at least 3 independent
experiments.
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by PCNA immunostaining of the lungs cultured in the
different chemically defined media. The PCNA index of
cells containing PCNA protein was determined as the PCNA
Index. Results indicated 88% T 3% (P < 0.05) more cell
proliferation in the epithelium of the VEGF 164-treated
explants than in controls (Fig. 7). The rate of cell
proliferation in the mesenchyme increased from 21% T 6%
to 39% T 4% (P < 0.05) in VEGF 164-treated explants.Conversely, the PCNA index (both epithelium and mesen-
chyme) was reduced from 39% T 2% to 16% T 2% (P <
0.05) in lung cultures containing Flk-1 antisense ODN
compared to control or scrambled ODN-treated lungs.
Discussion
Early embryonic lung development depends on a delicate
balance between different growth factors. While endodermal
Fig. 5. Effect of the abrogation of Flk-1 receptor mRNA expression on specific gene expression. Competitive RT-PCR data were quantified by densitometric
analysis, with normalization to h-actin (G). 40 AM Flk-1 antisense ODN significantly decreased endogenous Flk-1 (B), Sp-c (D), and Bmp-4 (F) mRNA levels by
92%, 59%, and 34% of their level of expression observed in control lungs, respectively (all *P < 0.05). Also 40 AM Flk-1 antisense ODN treatment resulted in
mSpry-2 (P), mSpry-4 (R) mRNA levels, 162% and 142% higher than those of the scrambled ODN and control medium (*P < 0.05). No change in Shh and Fgf10
expression was observed (not shown). Values are expressed as the mean T SD with the medium control set at 100%. Results are presented as means T SD, n = 15,
combining from at least 3 independent experiments.
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2002; Warburton et al., 2000), relatively little is known about
the specific role of the mesenchyme and especially endothelial
cells during lung epithelial morphogenesis (Lammert et al.,
2003). We therefore decided to compare the effect of
exogenous VEGF 164, a specific isoform of VEGF-A, versus
Flk-1 downregulation on early mouse lung embryonic mor-
phogenesis in our well-characterized serumless culture system.
Our results demonstrate a novel positive impact of the VEGF-
A signaling pathway in triggering an increase in epithelial
morphogenesis. Our results also show that Vegf-A, expressed
by the epithelium acts in a paracrine fashion on endothelial
cells (Clauss et al., 1996; Keyt et al., 1996) to control epithelial
morphogenesis.
In agreement with our observations, defective pulmonary
development is observed in the absence of heparin sulfate-
bound VEGF isoforms 164 and 188 (Galambos et al.,
2002).Interestingly, lower levels of both Vegf-A and Flk-1 mRNA
were found in lungs of mice overexpressing TGF-beta in the
distal lung epithelium associated with an arrest in lung
morphogenesis in the pseudoglandular stage (Zeng et al.,
2001). Abnormal lung structure was previously associated
with inhibition of the tyrosine kinase activity of Flk-1 by Su-
5416 (Jakkula et al., 2000; Le Cras et al., 2002). Lower
expression levels of both VEGF-A and Flk-1 were also
observed in embryonic hypoplastic lungs after nitrofen
treatment (Chinoy et al., 2002). In contrast, intrauterine
injection of hVEGF 165 into the amniotic cavity had a
pneumotrophic effect stimulating surfactant production in
mice (Compernolle et al., 2002).
The herein observed enhancement of lung epithelial
branching by VEGF 164 is not likely to be mediated by a
direct effect of VEGF 164 on the epithelium, since Flk-1 is
expressed by the mesenchyme. Therefore, there must be a
mesenchymal to epithelial relay mechanism for VEGF 164 to
Table 2
Quantification of competitive RT-PCR data in Flk-1 antisense ODN-treated vs. control lungs or scrambled ODN-treated vs. control lungs by densitometric
measurement













b-actin Control Competitor 2209 T 155 1.08 1.07 +7
Gene 2378 T 214
Flk-1 AS ODN Competitor 1867 T 112 1.15
Gene 2154 T 108 1.02 +2
Scrambled ODN Competitor 2456 T 239 1.10
Gene 2686 T 192
Flk-1 Control Competitor 4034 T 270 0.69 0.08 92
Gene 2789 T 252
Flk-1 AS ODN Competitor 4699 T 188 0.05
Gene 252 T 30 1.06 +6
Scrambled ODN Competitor 4526 T 362 0.74
Gene 3344 T 386
Sp-c Control Competitor 4702 T 376 0.89 0.41 59
Gene 4195 T 503
Flk-1 AS ODN Competitor 4999 T 465 0.36
Gene 1807 T 289 1.10 +10
Scrambled ODN Competitor 5056 T 391 0.98
Gene 4972 T 568
mSpy2 Control Competitor 4771 T 190 0.36 2.62 +162
Gene 1718 T 198
Flk-1 AS ODN Competitor 4814 T 239 0.94
Gene 4539 T 621 1.05 +5
Scrambled ODN Competitor 5050 T 358 0.38
Gene 1912 T 204
mSpry4 Control Competitor 3807 T 267 0.37 2.42 +142
Gene 1395 T 70
Flk-1 AS ODN Competitor 3614 T 326 0.88
Gene 3201 T 290 0.95 5
Scrambled ODN Competitor 3586 T 435 0.34
Gene 1248 T 187
Bmp-4 Control Competitor 4478 T 438 0.78 0.66 34
Gene 3501 T 475
Flk-1 AS ODN Competitor 4534 T 182 0.52
Gene 2346 T 194 0.98 2
Scrambled ODN Competitor 4592 T 604 0.77
Gene 3532 T 539
Quantification of competitive RT-PCR data by densitometric analysis. For each gene, the density of the band corresponding to the gene or the competitor was
measured as Intensity/mm2 T SD. A ratio gene/competitor was determined for the control, the Flk-1 antisense ODN, or the scrambled ODN-treated explants. The Flk-
1 antisense ratio by the control ratio was calculated to determine the difference in mRNA expression in Flk-1 antisense-treated versus control lung. The scrambled
antisense ratio by the control ratio was calculated to determine the difference in mRNA expression in scrambled antisense-treated versus control lung.
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morphogens released by the endothelium as a result of VEGF
164 activity on these cells.
In the lung, endothelial derived signals have been shown
previously to be crucial to epithelial maturation and morpho-
genesis. Inhibition of neovascularization by endothelial mono-
cyte activating peptide (EMAP) II prevented endothelial cell
proliferation and resulted in a marked alteration in lung
morphogenesis (Schwarz et al., 2000).
In the liver, where morphogenetic signals have also been
shown to come from endothelial cells, it has been observed that
hepatocytes from Flk-1 mutant embryos fail to migrate away
from the epithelium. In fact, embryonic livers from Flk-1 null
mice in culture develop the initial epithelial layer but
subsequently epithelial cells fail to migrate into the surround-
ing septum transversum (Matsumoto et al., 2001). Partialinhibition of VEGF-A in the liver also resulted in impaired
organogenesis (Gerber et al., 1999).
Interestingly, endothelial signals have been shown to induce
pancreatic development (Lammert et al., 2003). Remarkably,
blood vessel endothelium induced insulin expression by
isolated pancreatic endoderm in vitro, while removal of the
dorsal aorta in Xenopus embryos resulted in the failure of
insulin expression. Moreover, ectopic vascularization in the
posterior foregut has been shown to induce ectopic insulin
production (Lammert et al., 2001). The nature of the
endothelial-derived signals inducing endocrine development
in the pancreas is not known so far.
Since the mitogenic and differentiating effects of VEGF-164
are likely to be mainly mediated through interaction with Flk-1
receptor (Clauss et al., 1996), we investigated the expression of
Flk-1 receptor using Flk-1n LacZ/+ E14.5 lungs. At this stage of
Fig. 6. Effect of exogenous VEGF 164 and of the abrogation of Flk-1 receptor
mRNA expression on Bmp-4LacZ/+ expression. h-galactosidase staining in
Bmp-4LacZ/+ cultured lungs with exogenous VEGF 164 (B) was clearly
increased compared to control lungs (A). However, in presence of Flk-1
antisense ODN (D), there was a significant decrease in h-galactosidase staining
compared to control media and scrambled ODN-treated lungs (C, E). Note that
the changes in expression only occurred within the distal tips of the epithelium.
Western analysis confirmed the respective up-regulation versus downregulation
of BMP-4 with VEGF 164 versus Flk-1 antisense ODN (F). Representative
Western blot showing that VEGF 164 treatment (150 ng/ml) on embryonic
lungs resulted in significant increased levels of BMP-4 (72% T 6%, P < 0.01).
Also, 40 AM Flk-1 antisense ODN reduced BMP-4 protein expression (63% T
7%, P < 0.01). Actin was used as loading control. Results are presented
combining from at least 3 independent experiments.
Fig. 7. Effect of exogenous VEGF 164 versus Flk-1 antisense ODN on epitheli
immunostaining of lungs cultured in presence or absence of VEGF 164 (A, B), or
increased by 88% T 3% indicating more cell proliferation in the epithelium of the V
the mesenchyme increased from 21% T 6% to 39% T 4% in VEGF 164-treated e
treatment decreased both epithelial and mesenchymal PCNA Index to 16% T 2% (D)
(A, E). There were no significant differences in PCNA Index between the scrambl
P.-M. Del Moral et al. / Developmental Biology 290 (2006) 177–188186development, we found this receptor exclusively expressed in
the mesenchyme. Previous data on Vegf-A and Flk-1 expres-
sion (Miquerol et al., 1999), isolated type II epithelial cells
(Raoul et al., 2004), and our results on isolated endoderm show
that VEGF-A does not have a proliferative or morphogenetic
effect on isolated endoderm. The possible mechanism of action
of VEGF-A must therefore be indirect in its role to regulate
epithelial branching. VEGF 164 stimulation of intact lung
explants is also associated to increased total cell proliferation as
indicated by PCNA index. VEGF-A may act through Flk-1-
positive cells in the mesenchyme to induce the expression of
other morphogens within the mesenchyme.
Bmp-4 expression was increased following exposure to
VEGF 164 in intact lung explants. However, the induction of
Bmp-4 occurred in the distal tips of the epithelium. Exogenous
BMP-4 increases peripheral lung epithelial branching morpho-
genesis, whereas adenoviral overexpression of the BMP
antagonist gremlin blocked the stimulatory effects of exoge-
nous BMP-4, demonstrating that BMP-4 plays an important
morphogenetic role during lung embryogenesis (Shi et al.,
2001). BMP-4 is also involved in branching morphogenesis of
the lung by modulating FGF10 induced morphogenesis
(Weaver et al., 2000).
Interestingly, the liver phenotype of null Flk-1 embryos is
similar to Bmp-4 deficient embryos where BMP-4 has been
shown to be critical for endodermal growth (Matsumoto et al.,
2001; Rossi et al., 2001). Therefore, BMP-4 may play a similar
morphogenetic role during both liver and lung embryonic
development.
Additionally, the expression of mouse Sprouty2 and 4,
another important class of inducible regulatory molecules
that have been, respectively, shown to participate inal and mesenchymal cell proliferation. Cell proliferation analysis by PCNA
in presence or absence of Flk-1 antisense ODN (C–E). The PCNA index was
EGF-treated explants than in the control (A, B). The rate of cell proliferation in
xplants compared to control media (A, B). Conversely, Flk-1 antisense ODN
compared to 39% T 2% in both control media and scrambled ODN-treated lungs
ed ODN cultured explants and the control lungs.
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Bmp-4 upon addition of exogenous VEGF 164 versus Flk-1
antisense ODN. However, the respective changes in mSpy2
and mSpy4 expression observed are not apparently related
directly to Fgf10, since Fgf10 expression is not affected by
exogenous VEGF 164 or Flk-1 antisense ODN treatment.
Decreased mSpy2 expression may facilitate epithelium
morphogenesis since ablation of mSpy2 expression in
cultured embryonic mouse lungs resulted in a significant
increase in lung branching morphogenesis (Tefft et al.,
1999). While, on the other hand, overexpression of mSpy2
in endothelial cells revealed its potential to negatively
regulate angiogenesis in response to FGF, VEGF, and EGF
receptor signaling (Impagnatiello et al., 2001). Moreover,
expression of mSpy4 in endothelial cells using a recombi-
nant adenovirus resulted in inhibition of branching and
sprouting of the vasculature (Lee et al., 2001), a phenotype
mediated through inhibition of MAPK activation in response
to FGF and VEGF. mSpy4 is also critical during the
pseudoglandular stage of embryonic lung morphogenesis,
since in vivo overexpression of mSpy4 during this time
period resulted in severe defects in lobulation and lung
hypoplasia (Perl et al., 2003).
Herein, we show that VEGF-A signaling acts as a
morphogen, inducing a significant increase in both epithelial
and endothelial branching morphogenesis in the early embry-
onic mouse lung in culture. However, the stimulating effect of
VEGF-A on the epithelium is probably indirect since Flk-1 is
only expressed in the mesenchyme. We also demonstrated that
epithelial Bmp-4 expression is, respectively, increased by
stimulation versus decreased by inhibition of the VEGF-A
signaling pathway, while the other changes in mSpy2 and 4
expression are the inverse of Bmp-4. Thus, VEGF-A signaling
exerts a positive role on lung epithelial and endothelial
morphogenesis. We speculate that VEGF-A signals function
in a critical morphogenetic role by mediating epithelial–
endothelial/mesenchymal cross talk.
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